Page last updated: 2024-11-03

propentofylline and Peritonitis

propentofylline has been researched along with Peritonitis in 1 studies

Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.

Research Excerpts

ExcerptRelevanceReference
"Propentofylline is an atypical xanthine derivative that blocks adenosine uptake and has been shown to protect against ischemia-induced cerebral damage."1.29Propentofylline inhibits polymorphonuclear leukocyte recruitment in vivo by a mechanism involving adenosine A2A receptors. ( Fredholm, BB; Hedqvist, P; Raud, J; Zhang, Y, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, Y1
Raud, J1
Hedqvist, P1
Fredholm, BB1

Other Studies

1 other study available for propentofylline and Peritonitis

ArticleYear
Propentofylline inhibits polymorphonuclear leukocyte recruitment in vivo by a mechanism involving adenosine A2A receptors.
    European journal of pharmacology, 1996, Oct-17, Volume: 313, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Male; Mice; Neutrophils; Peritonitis; Purinergic P1 Receptor Antagonists

1996